-
Je něco špatně v tomto záznamu ?
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
G. Plitas, C. Konopacki, K. Wu, PD. Bos, M. Morrow, EV. Putintseva, DM. Chudakov, AY. Rudensky,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Cell Press Free Archives
od 1994-04-01 do Před 1 rokem
Free Medical Journals
od 1995 do Před 1 rokem
- MeSH
- dospělí MeSH
- fenotyp MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- nádory prsu imunologie MeSH
- průtoková cytometrie MeSH
- receptory CCR8 biosyntéza imunologie MeSH
- regulační T-lymfocyty imunologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- separace buněk MeSH
- stanovení celkové genové exprese MeSH
- transkriptom MeSH
- tumor infiltrující lymfocyty MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Regulatory T (Treg) cells reside in lymphoid organs and barrier tissues where they control different types of inflammatory responses. Treg cells are also found in human cancers, and studies in animal models suggest that they contribute to cancer progression. However, properties of human intratumoral Treg cells and those present in corresponding normal tissue remain largely unknown. Here, we analyzed features of Treg cells in untreated human breast carcinomas, normal mammary gland, and peripheral blood. Tumor-resident Treg cells were potently suppressive and their gene-expression pattern resembled that of normal breast tissue, but not of activated peripheral blood Treg cells. Nevertheless, a number of cytokine and chemokine receptor genes, most notably CCR8, were upregulated in tumor-resident Treg cells in comparison to normal tissue-resident ones. Our studies suggest that targeting CCR8 for the depletion of tumor-resident Treg cells might represent a promising immunotherapeutic approach for the treatment of breast cancer.
Bioinformatics and Genomics Programme Centre for Genomic Regulation Barcelona 08003 Spain
Breast Service Department of Surgery Memorial Sloan Kettering Cancer Center New York NY 10065 USA
Central European Institute of Technology Brno 60177 Czech Republic
Massey Cancer Center Virginia Commonwealth University School of Medicine Richmond VA 23298 USA
Pirogov Russian National Research Medical University Moscow 117997 Russia
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry Moscow 117997 Russia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031290
- 003
- CZ-PrNML
- 005
- 20171103113003.0
- 007
- ta
- 008
- 171025s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.immuni.2016.10.032 $2 doi
- 035 __
- $a (PubMed)27851913
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Plitas, George $u Howard Hughes Medical Institute, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Ludwig Center at Memorial Sloan Kettering Cancer Center, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- 245 10
- $a Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer / $c G. Plitas, C. Konopacki, K. Wu, PD. Bos, M. Morrow, EV. Putintseva, DM. Chudakov, AY. Rudensky,
- 520 9_
- $a Regulatory T (Treg) cells reside in lymphoid organs and barrier tissues where they control different types of inflammatory responses. Treg cells are also found in human cancers, and studies in animal models suggest that they contribute to cancer progression. However, properties of human intratumoral Treg cells and those present in corresponding normal tissue remain largely unknown. Here, we analyzed features of Treg cells in untreated human breast carcinomas, normal mammary gland, and peripheral blood. Tumor-resident Treg cells were potently suppressive and their gene-expression pattern resembled that of normal breast tissue, but not of activated peripheral blood Treg cells. Nevertheless, a number of cytokine and chemokine receptor genes, most notably CCR8, were upregulated in tumor-resident Treg cells in comparison to normal tissue-resident ones. Our studies suggest that targeting CCR8 for the depletion of tumor-resident Treg cells might represent a promising immunotherapeutic approach for the treatment of breast cancer.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a nádory prsu $x imunologie $7 D001943
- 650 _2
- $a separace buněk $7 D002469
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tumor infiltrující lymfocyty $7 D016246
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a receptory CCR8 $x biosyntéza $x imunologie $7 D054401
- 650 _2
- $a regulační T-lymfocyty $x imunologie $7 D050378
- 650 _2
- $a transkriptom $7 D059467
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Konopacki, Catherine $u Howard Hughes Medical Institute, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- 700 1_
- $a Wu, Kenmin $u Howard Hughes Medical Institute, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Ludwig Center at Memorial Sloan Kettering Cancer Center, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- 700 1_
- $a Bos, Paula D $u Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
- 700 1_
- $a Morrow, Monica $u Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- 700 1_
- $a Putintseva, Ekaterina V $u Bioinformatics and Genomics Programme, Centre for Genomic Regulation Barcelona 08003, Spain; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow 117997, Russia.
- 700 1_
- $a Chudakov, Dmitriy M $u Central European Institute of Technology, Brno 60177, Czech Republic; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow 117997, Russia; Pirogov Russian National Research Medical University, Moscow 117997, Russia.
- 700 1_
- $a Rudensky, Alexander Y $u Howard Hughes Medical Institute, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Ludwig Center at Memorial Sloan Kettering Cancer Center, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: rudenska@mskcc.org.
- 773 0_
- $w MED00002186 $t Immunity $x 1097-4180 $g Roč. 45, č. 5 (2016), s. 1122-1134
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27851913 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171103113057 $b ABA008
- 999 __
- $a ok $b bmc $g 1254883 $s 992317
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 45 $c 5 $d 1122-1134 $i 1097-4180 $m Immunity $n Immunity $x MED00002186
- LZP __
- $a Pubmed-20171025